| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |